Buscar resultados de ensayos clínicos
Rubella - 19 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Rubella Susceptibility in Multiparous Women Condición:
Fecha: 2006-11-17 |
Completed |
Nombre del estudio: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination Condición: Measles/Rubella Fecha: 2014-06-04 Intervenciones: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
Completed |
Nombre del estudio: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination Condición: Measles/Rubella Fecha: 2014-05-28 Intervenciones: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
Not yet recruiting |
Nombre del estudio: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella Condición:
Fecha: 2017-05-09 Intervenciones:
|
Completed |
Nombre del estudio: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Condición:
Fecha: 2014-07-16 Intervenciones: Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm |
Completed |
Nombre del estudio: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condición: Measles; Mumps; Rubella Fecha: 2014-07-03 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Condición:
|
Completed |
Nombre del estudio: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Condición:
Fecha: 2013-01-21 Intervenciones: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin |
Completed |
Nombre del estudio: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Condición:
Fecha: 2014-02-06 Intervenciones: |
Completed |
Nombre del estudio: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Condición:
Fecha: 2012-06-14 Intervenciones: |